{"id":51812,"date":"2023-09-20T09:25:29","date_gmt":"2023-09-20T09:25:29","guid":{"rendered":"https:\/\/medsname.com\/nebicard\/"},"modified":"2026-08-28T11:46:17","modified_gmt":"2026-08-28T11:46:17","slug":"nebicard","status":"publish","type":"product","link":"https:\/\/medsbase.com\/da\/nebicard\/","title":{"rendered":"Nebicard"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin: 0 0 8px 0; font-size: 16px; font-weight: bold;\">\u26a1 Quick Answer \u2014 What is Nebicard?<\/h3>\n<p style=\"margin: 0;\"><strong>Nebicard<\/strong> er en <strong>2,5 mg \/ 5 mg nebivolol tablet<\/strong> from Torrent Pharmaceuticals \u2014 ultra-selective beta-1 blocker with additional nitric-oxide-mediated vasodilation. Primary use is <strong>forh\u00f8jet blodtryk<\/strong>; bruges ogs\u00e5 til angina, kontrol af arytmier, sekund\u00e6r forebyggelse efter myocardieinfarkt. Foretrukket hos \u00e6ldre, metabolisk syndrom og patienter med erektil dysfunktion. Typisk dosis ved hypertension: <strong>5 mg en gang dagligt (interval 2,5-10 mg). Start med 2,5 mg hos \u00e6ldre eller ved nyreinsufficiens.<\/strong> Kontraindikeret ved <strong>astma (relativt for kardioselektive midler; absolut for ikke-selektive), alvorlig bradykardi, anden\/tredjegrads hjerteblok, akut dekompenseret hjertesvigt og ph\u00e6ochromocytom uden forudg\u00e5ende alfa-blokade<\/strong>. Do NOT stop abruptly \u2014 taper over 1-2 weeks to avoid rebound tachycardia \/ angina \/ MI.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Hvad du f\u00e5r med MedsBase:<\/strong> WHO-GMP certificeret producent \u00b7 Diskret emballage \u00b7 Verdensomsp\u00e6ndende forsendelse \u00b7 1.400+ verificerede <a href=\"https:\/\/medsbase.com\/da\/reviews\/\">kundeanmeldelser<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Hver ordre er d\u00e6kket af vores <a href=\"https:\/\/medsbase.com\/da\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n<h3>Hvorfor bestille fra MedsBase<\/h3>\n<p>Vores generiske l\u00e6gemidler kommer fra WHO-GMP-certificerede producenter og sendes verdensrundt i diskret, neutral emballage \u2014 ingen l\u00e6gemiddelnavn p\u00e5 pakkens ydre. Kortbetalinger h\u00e5ndteres af en reguleret processor (kontoudtogsbeskrivelser inkluderer en reguleret betalingsprocessor \u2014 aldrig \u201cMedsBase\u201d eller noget l\u00e6gemiddelnavn). Crypto og SEPA bankoverf\u00f8rsel accepteres ogs\u00e5. Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy.<\/p>\n<h2 class=\"wp-block-heading\">Hvad er Nebicard?<\/h2>\n<p>Nebicard er en oral tablet, der indeholder <strong>nebivolol 2,5 mg \/ 5 mg<\/strong> fra Torrent Pharmaceuticals, leveres i 30-180 tabletter. Nebivolol er en ultraselektiv beta-1-blokker med yderligere nitritoxid-medieret vasodilatation. Tredjegenerations betablokker med den <strong>h\u00f8jeste beta-1-selektivitet af alle klinisk anvendte midler<\/strong> (roughly 10\u00d7 more selective than bisoprolol) and a unique property: it releases nitric oxide in the vascular endothelium, producing direct vasodilation. Evidence from the <strong>SENIORS-studiet<\/strong> for elderly heart failure (heart failure with preserved ejection fraction included \u2014 unusual for a beta-blocker).<\/p>\n<h2 class=\"wp-block-heading\">Hvordan Nebivolol S\u00e6nker Blodtrykket<\/h2>\n<p>Beta-blokkere reducerer blodtrykket gennem fire mekanismer:<\/p>\n<ul>\n<li><strong>Reduktion af hjertets minutvolumen<\/strong> \u2014 beta-1 blockade in the sinoatrial node reduces heart rate, and blockade in ventricular myocardium reduces contractility. Lower cardiac output = lower blood pressure.<\/li>\n<li><strong>Suppression af renin-angiotensin-systemet<\/strong> \u2014 beta-1 blockade in juxtaglomerular cells reduces renin release, lowering angiotensin II and aldosterone over 2-4 weeks. This accounts for much of the long-term BP effect.<\/li>\n<li><strong>Reduktion af central sympatisk aktivitet<\/strong> \u2014 lipophilic beta-blockers cross the blood-brain barrier and reduce central sympathetic outflow.<\/li>\n<li><strong>Nitritoxid-medieret vasodilatation<\/strong> (nebivolol-specific) \u2014 endothelial NO release produces direct arterial relaxation alongside the beta-blockade effect.<\/li>\n<\/ul>\n<p>Betablokkere er <strong>moderat lipofil<\/strong>. Plasma halveringstid for nebivolol er 10-44 timer (afh\u00e6ngig af metaboliseringsstatus).<\/p>\n<h2 class=\"wp-block-heading\">Godkendte og evidensbaserede anvendelser<\/h2>\n<ul>\n<li><strong>Hypertension<\/strong> (prim\u00e6r indikation)<\/li>\n<li><strong>Hjertesvigt hos \u00e6ldre<\/strong> (&gt;70 years) \u2014 SENIORS evidence<\/li>\n<li><strong>Hypertension med metabolt syndrom<\/strong> \u2014 favourable on glucose\/lipid profile vs older beta-blockers<\/li>\n<li><strong>Hypertension hos patienter med erektil dysfunktion<\/strong> \u2014 less sexual-dysfunction impact than propranolol \/ atenolol; in some studies, improved endothelial function improves erectile function<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Nebicard-dosering<\/h2>\n<p><strong>Dosis til voksne med hypertension:<\/strong> 5 mg en gang dagligt (interval 2,5-10 mg). Start med 2,5 mg hos \u00e6ldre eller ved nyreinsufficiens.<\/p>\n<p>Start low, titrate upward over 2-4 weeks to target BP (typically &lt;140\/90 in uncomplicated hypertension; &lt;130\/80 in diabetes, chronic kidney disease, or established cardiovascular disease). Check resting pulse before each dose-increase \u2014 do not titrate if &lt;55 bpm.<\/p>\n<p><strong>Overv\u00e5gning:<\/strong><\/p>\n<ul>\n<li>Kontroller hvilepuls og blodtryk efter 2, 4 og 8 uger ved p\u00e5begyndelse eller dosis\u00e6ndring<\/li>\n<li>Baseline EKG ved hjertesygdom i anamnesen; periodisk EKG hvis symptomer \u00e6ndres<\/li>\n<\/ul>\n<p><strong>Administration:<\/strong> slug hele med vand. Indtag p\u00e5 cirka samme tidspunkt hver dag.<\/p>\n<p><strong>Oph\u00f8r:<\/strong> <strong>Oph\u00f8r ALDRI pludseligt.<\/strong> Taper over 1-2 weeks (reduce by 25-50% every 3-5 days). Abrupt discontinuation causes rebound tachycardia, worsened angina, and \u2014 in patients with coronary disease \u2014 can precipitate myocardial infarction. This is one of the most important safety points for beta-blockers.<\/p>\n<h2 class=\"wp-block-heading\">Bivirkninger<\/h2>\n<p><strong>Almindelige (&gt;5%):<\/strong><\/p>\n<ul>\n<li><strong>Tr\u00e6thed, sl\u00f8vhed<\/strong> \u2014 often adapts over 2-4 weeks<\/li>\n<li><strong>Kolde h\u00e6nder og f\u00f8dder<\/strong> (perifer vasokonstriktion)<\/li>\n<li><strong>Bradykardi<\/strong> (kontroller puls; stop hvis &lt;50 slag\/minut)<\/li>\n<li><strong>Nedsat fysisk udholdenhed<\/strong> \u2014 maximum heart rate is blunted by beta blockade<\/li>\n<li>Svimmelhed, postural hypotoni<\/li>\n<li>CNS-bivirkninger mulige, men mindre almindelige end med propranolol<\/li>\n<li>Postural svimmelhed (mere almindelig pga. vasodilaterende komponent)<\/li>\n<\/ul>\n<p><strong>Mindre almindelige:<\/strong> depression, nedsat libido \/ erektil dysfunktion, gastrointestinal ubehag, Raynaud-lignende kuldeintolerance, bronkospasme (mere almindelig med ikke-selektive midler).<\/p>\n<p><strong>Vigtigt men ualmindeligt:<\/strong><\/p>\n<ul>\n<li><strong>Maskeret hypoglyk\u00e6mi hos diabetikere<\/strong> \u2014 beta-blockers blunt the tachycardia \/ tremor warning signs of low blood sugar. Monitor glucose more carefully; prefer <a href=\"https:\/\/medsbase.com\/da\/concor\/\">bisoprolol<\/a> ved insulinbehandlet diabetes.<\/li>\n<li><strong>Bronkospasme<\/strong> \u2014 can be severe in asthma \/ COPD. Absolute contraindication for non-selective agents; relative for cardioselective.<\/li>\n<li><strong>Hjerteblok eller forv\u00e6rret hjerteinsufficiens<\/strong> \u2014 in susceptible patients. Start low, titrate slowly.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikationer og forsigtighedsregler<\/h2>\n<ul>\n<li><strong>Sv\u00e6r astma \/ sv\u00e6r KOL<\/strong> \u2014 relative contraindication (cardioselectivity is relative, not absolute)<\/li>\n<li>Anden- eller tredjegrads atrioventrikul\u00e6r blok (uden pacemaker)<\/li>\n<li>Sinustakykardi &lt;50 slag\/minut<\/li>\n<li>Kardiogen shock, dekompenseret hjerteinsufficiens der kr\u00e6ver inotroper behandling<\/li>\n<li>Alvorlig perifer arteriel sygdom, Raynauds syndrom (relativ)<\/li>\n<li>Phaeochromocytoma without prior alpha-blockade \u2014 paradoxical hypertensive crisis (never use a beta-blocker before alpha-blocker)<\/li>\n<li>Alvorlig leversvigt (for st\u00e6rkt lever-metaboliserede midler: propranolol, metoprolol, carvedilol, labetalol)<\/li>\n<li>Severe renal impairment \u2014 dose adjustment needed for renal-excreted agents (atenolol, nadolol)<\/li>\n<li>Overf\u00f8lsomhed overfor nebivolol<\/li>\n<\/ul>\n<p><strong>Graviditet:<\/strong> Kategori C; passerer placenta; lille risiko for intrauterin v\u00e6ksth\u00e6mning, neonatal bradykardi og hypoglyk\u00e6mi. Brug kun hvis fordel klart opvejer risiko; <a href=\"https:\/\/medsbase.com\/da\/labebet\/\">labetalol<\/a> er det foretrukne beta-blokker under graviditet.<\/p>\n<p><strong>Amning:<\/strong> sm\u00e5 m\u00e6ngder i moderm\u00e6lk; generelt betragtes som forenelig med monitorering.<\/p>\n<h2 class=\"wp-block-heading\">L\u00e6gemiddelinteraktioner<\/h2>\n<ul>\n<li><strong>Verapamil, diltiazem<\/strong> (non-dihydropyridine CCBs) \u2014 additive bradycardia, heart block, and negative inotropy; generally avoid combination. Dihydropyridine CCBs (<a href=\"https:\/\/medsbase.com\/da\/amlode\/\">amlodipine<\/a>, nifedipin) er sikrere at kombinere med beta-blokkere.<\/li>\n<li><strong>Andre beta-blokkere<\/strong> \u2014 do not combine; additive bradycardia<\/li>\n<li><strong>Clonidine<\/strong> \u2014 if stopping clonidine, stop the beta-blocker first (several days before) to avoid rebound hypertensive crisis<\/li>\n<li><strong>Insulin og sulfonylurinstoffer<\/strong> \u2014 mask hypoglycaemia warning signs; monitor glucose closely<\/li>\n<li><strong>NSAID'er<\/strong> \u2014 reduce the antihypertensive effect of beta-blockers; avoid chronic combination<\/li>\n<li><strong>Alkohol<\/strong> \u2014 additive hypotension and CNS depression (particularly for lipophilic agents)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Betablokker-klassen p\u00e5 et glimt<\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 14px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Betablokker<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selektivitet<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Bedst til<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/da\/inderal\/\">Propranolol (Inderal, Ciplar, Beloc)<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ikke-selektiv<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Migr\u00e6ne, tremor, thyreotoksikose, pr\u00e6stationsangst, HTN<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/da\/betablock-xl\/\">Metoprolol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Kardioselektiv<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Post-MI, HF-REF (succinat ER), angina, AF-hastighedskontrol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/da\/carvejohn\/\">Carvedilol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non-selective + \u03b1-1<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">HF-REF (d\u00f8delighedsevidence), post-MI<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/da\/concor\/\">Bisoprolol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">H\u00f8jt kardioselektiv<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">HF-REF, HTN, angina, AF frekvenskontrol<\/td>\n<\/tr>\n<tr style=\"background: #fff3cd;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/da\/nebicard\/\">Nebivolol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ultra-selektiv + NO<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u00c6ldre, metabolisk syndrom, erektil dysfunktion<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/da\/atenheal\/\">Atenolol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Kardioselektiv (hydrofil)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Angina, AF rate control (andenrangsvalg ved HTN)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/da\/labebet\/\">Labetalol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non-selective + \u03b1-1<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Graviditetshypertension, hypertensiv krise<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Foretrukken betablokker hos \u00e6ldre patienter, patienter med metabolt syndrom eller nedsat glukosetolerance samt m\u00e6nd med erektil dysfunktion.<\/strong> Ultrah\u00f8j beta-1-selektivitet betyder, at det generelt tolereres ved mild til moderat astma (stadig ikke absolut sikkert; anvend med forsigtighed og monitorering). NO-medieret vasodilatation giver det et blodtrykss\u00e6nkende profil t\u00e6ttere p\u00e5 en calciumkanalblokker end en klassisk betablokker.<\/p>\n<h2 class=\"wp-block-heading\">Opbevaring<\/h2>\n<p>Store Nebicard below 25\u00b0C. Keep out of reach of children \u2014 accidental paediatric beta-blocker ingestion can cause life-threatening bradycardia and hypoglycaemia.<\/p>\n<h2 id=\"faqs\">Ofte stillede sp\u00f8rgsm\u00e5l<\/h2>\n<h3 class=\"wp-block-heading\">Hvor lang tid tager Nebicard at s\u00e6nke blodtrykket?<\/h3>\n<p>Du b\u00f8r se en vis reduktion i blodtrykket inden for 1-2 dage efter start; den <strong>fulde antihypertensive effekt tager 2-4 uger<\/strong> (drevet af den gradvise undertrykkelse af renin-angiotensin-systemet, ikke den umiddelbare hjertefrekvenseffekt). M\u00e5l blodtrykket derhjemme p\u00e5 samme tidspunkt hver dag for at f\u00f8lge responsen.<\/p>\n<h3 class=\"wp-block-heading\">Kan jeg tage Nebicard, hvis jeg har astma?<\/h3>\n<p><strong>Nebivolol er ultraselektiv + NO-frigivelse, s\u00e5 det er relativt sikrere ved astma end ikke-selektive midler.<\/strong> Imidlertid er kardioselektiviteten <em>relativ<\/em> \u2014 at higher doses beta-2 blockade can still occur. In severe or brittle asthma, avoid all beta-blockers if possible. In mild asthma or COPD, use with monitoring and inhaler access.<\/p>\n<h3 class=\"wp-block-heading\">Hvorfor skal jeg aldrig stoppe Nebicard pludseligt?<\/h3>\n<p>Pludselig afbrydelse for\u00e5rsager <strong>rebound-takykardi og forv\u00e6rret angina<\/strong> inden for 24-48 timer, drevet af opregulering af beta-receptorer under kronisk blokade. Hos patienter med kransp\u00e5rssygdom kan dette udl\u00f8se myocardieinfarkt eller ustabil angina. Altid trappes ned over 1-2 uger ved oph\u00f8r.<\/p>\n<h3 class=\"wp-block-heading\">Vil Nebicard p\u00e5virke min tr\u00e6ningspr\u00e6station?<\/h3>\n<p>Yes \u2014 beta blockade blunts the heart-rate response to exercise, so your maximum pulse is lower and you fatigue faster at high intensities. For recreational exercise most people adapt; for competitive endurance athletes, beta-blockers can meaningfully impair performance and are banned in precision sports (shooting, archery \u2014 where they reduce physiological tremor).<\/p>\n<h3 class=\"wp-block-heading\">Vil Nebicard p\u00e5virke mit blodsukker, hvis jeg har diabetes?<\/h3>\n<p>Betablokkere <strong>maskerer takykardi\/tremor\/hjertebanken-varselstegn p\u00e5 hypoglyk\u00e6mi<\/strong>, hvilket g\u00f8r lavt blodsukker sv\u00e6rere at opdage. De kan ogs\u00e5 d\u00e6mpe den modregulerende glukoserespons. Overv\u00e5g glukose hyppigere under betablokkerbehandling, is\u00e6r hvis du tager insulin eller sulfonylurinstof. <a href=\"https:\/\/medsbase.com\/da\/nebicard\/\">Nebivolol<\/a> og <a href=\"https:\/\/medsbase.com\/da\/concor\/\">bisoprolol<\/a> har det bedste metaboliske profil.<\/p>\n<h3 class=\"wp-block-heading\">Kan jeg drikke alkohol, mens jeg tager Nebicard?<\/h3>\n<p>Moderat alkohol er generelt acceptabelt, men alkohol forst\u00e6rker de hypotensive og CNS-deprimerende virkninger. Rejs dig langsomt op efter at have drukket. Alkohol er ogs\u00e5 en uafh\u00e6ngig blodtryksforh\u00f8jer; reduktion af indtaget kan forbedre blodtrykskontrol uafh\u00e6ngigt af Nebicard.<\/p>\n<h3 class=\"wp-block-heading\">For\u00e5rsager Nebicard v\u00e6gt\u00f8gning?<\/h3>\n<p>\u00c6ldre betablokkere (propranolol, atenolol, metoprolol) er forbundet med beskeden v\u00e6gt\u00f8gning (1-3 kg) og forv\u00e6rring af insulinf\u00f8lsomhed over tid. <strong>Nebivolol og carvedilol er v\u00e6gtneutrale eller let v\u00e6gtfav\u00f8rlige<\/strong> p\u00e5 grund af deres vasodilaterende komponenter. For patienter med metabolt syndrom, <a href=\"https:\/\/medsbase.com\/da\/nebicard\/\">nebivolol<\/a> er den foretrukne betablokker, n\u00e5r det er n\u00f8dvendigt.<\/p>\n<h3 class=\"wp-block-heading\">Er Nebicard sikkert under graviditet?<\/h3>\n<p>Kategori C. Brug kun, hvis fordelen klart opvejer risikoen. Til antihypertensiv brug under graviditet, <a href=\"https:\/\/medsbase.com\/da\/labebet\/\">labetalol<\/a> er den foretrukne beta-blokker; methyldopa og nifedipin er de to andre graviditetssikre muligheder.<\/p>\n<h3 class=\"wp-block-heading\">Kan jeg tage Nebicard sammen med andre blodtryksmedicin?<\/h3>\n<p>Yes \u2014 beta-blockers combine well with <strong>dihydropyridin calciumkanalblokkere<\/strong> (<a href=\"https:\/\/medsbase.com\/da\/amlode\/\">amlodipine<\/a>), <strong>ACE-h\u00e6mmere<\/strong> (ramipril, lisinopril), <strong>ARB'er<\/strong> (<a href=\"https:\/\/medsbase.com\/da\/losar\/\">losartan<\/a>, <a href=\"https:\/\/medsbase.com\/da\/telmaheal\/\">telmisartan<\/a>, <a href=\"https:\/\/medsbase.com\/da\/olmin\/\">olmesartan<\/a>), og <strong>thiazid-diuretika<\/strong> (<a href=\"https:\/\/medsbase.com\/da\/aquazide\/\">HCTZ<\/a>). <strong>Undg\u00e5 kombination med ikke-dihydropyridin CCB'er<\/strong> (verapamil, diltiazem) \u2014 additive bradycardia and heart-block risk.<\/p>\n<h3 class=\"wp-block-heading\">Hvor kan jeg k\u00f8be Nebicard online?<\/h3>\n<p>Du kan k\u00f8be Nebicard (nebivolol 2,5 mg \/ 5 mg tablet, 30-180 tabletter) fra MedsBase med diskret emballage og verdensomsp\u00e6ndende forsendelse.<\/p>\n<h2 class=\"wp-block-heading\">Relaterede Beta-Blockere &amp; Antihypertensiva<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/da\/beloc\/\">Beloc \u2014 Propranolol 10\/20\/40 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/carloc\/\">Carloc \u2014 Carvedilol 3.125 mg (HF starter)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/ciplar\/\">Ciplar \u2014 Propranolol 10 mg (Cipla)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/inderal\/\">Inderal \u2014 Propranolol IR 20\/40 mg (AstraZeneca)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/p-nolol-sr\/\">P-Nolol SR \u2014 Propranolol 80 mg sustained-release<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/provanol-sr\/\">Provanol SR \u2014 Propranolol 80 mg SR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/high-blood-pressure-medication\/\"><strong>Gennemse alle l\u00e6gemidler mod forh\u00f8jet blodtryk<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background: #fff3f3; border-left: 4px solid #d9534f; padding: 16px 20px; margin: 24px 0; border-radius: 4px;\"><strong>\u2695 Medical Disclaimer.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Hypertension, heart failure, and arrhythmias require diagnosis, monitoring, and dose individualisation by a doctor \u2014 always use beta-blockers under medical guidance.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterede alternativer<\/h3>\n<p>Andre produkter inden for <strong>Kroniske tilstande<\/strong> som kunder ogs\u00e5 ser:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/da\/voritrol\/\">Voritrol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/flexabenz-er\/\">Flexabenz ER<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/rofaday\/\">Rofaday<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/doxolin\/\">Doxolin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/tofe\/\">Tofe<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Nebicard er nebivolol 2,5\/5 mg tabletter fra Torrent \u2014 en ultraselektiv beta-1-bloker med nitroxid-medieret vasodilatation. Foretrukken beta-bloker hos \u00e6ldre, patienter med metabolisk syndrom og erektil dysfunktion. Til hypertension (5-10 mg en gang dagligt) og hjertesvigt hos \u00e6ldre. Bedre metabolisk profil end atenolol\/metoprolol.<\/p>","protected":false},"featured_media":51813,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3415,3416],"class_list":{"0":"post-51812","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-nebicard","11":"product_tag-nebivolol","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product\/51812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/comments?post=51812"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media\/51813"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media?parent=51812"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_brand?post=51812"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat?post=51812"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_tag?post=51812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}